Study on All-Trans Retinoic Acid, Induction and Consolidation Therapy, and Pegfilgrastim After Consolidation Therapy in Younger Patients With Newly Diagnosed Acute Myeloid Leukemia

NCT00151242 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

920

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: Cytarabine
DRUG: Idarubicin
DRUG: Etoposide
DRUG: All-trans retinoic acid
DRUG: Pegfilgrastim

Sponsor

University of Ulm